Stock Price
2.17
Daily Change
-0.18 -7.66%
Monthly
-3.98%
Yearly
69.53%
Q2 Forecast
2.13

Galectin Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 3.1 0.19 Mar/2026
Bristol-Myers Squibb 4.12 3.9 Mar/2026
Galectin Therapeutics 0 0 Mar/2025
Gilead Sciences 2.29 0.29 Mar/2026
Merck 2.76 0.36 Mar/2026